The Board of Alterity Therapeutics announced the appointment of Dr. David Stamler to the role of Chief Executive Office effective immediately. Dr. Stamler joined the Company in June 2017 as Chief Medical Officer and Senior Vice President Clinical Development. Mr. Geoffrey Kempler, who founded the company in November 1997, will step down from the role of CEO and continue as Non-Executive Chairman. Mr. Kempler will be engaged in a consulting capacity in addition to his Non-Executive Chairman role.